The adjusted odds ratio for dementia risk associated with gabapentin use was 0.91 (95 % C.I. 0.83 1.01), indicating no substantial increase in risk. Conclusion Long-term Gabapentin therapy for chronic pain is not associated with a differential risk of dementia across dosage levels, irrespective of age or gender.
Exploring the association between gabapentin use and the risk of dementia reveals a significant concern based on recent research findings. Studies have shown a potential link between gabapentinoids, including gabapentin, and an increased risk of cognitive decline and dementia in older adults.
No significant difference in the risk of dementia was found between low and high cumulative doses of gabapentin. The adjusted odds ratio for dementia risk associated with gabapentin use was 0.91 (95 % C.I. 0.83 1.01), indicating no substantial increase in risk.
Rising global dementia prevalence is drawing attention to chronic pain as a potential risk factor often managed by gabapentin. Taiwanese health insurance database spanning assessed dementia risk in gabapentin-using chronic pain. The study showed that gabapentin use not linked to higher dementia risk.
The hazard ratio (HR) for dementia in the exposure group was 1.45, signifying a significant correlation between gabapentin use and dementia risk. Regular use of gabapentinoids for conditions such as epilepsy may elevate the risk of cognitive impairment and dementia.
Exploring the association between gabapentin use and the risk of dementia reveals a significant concern based on recent research findings. Studies have shown a potential link between gabapentinoids, including gabapentin, and an increased risk of cognitive decline and dementia in older adults.
Rising global dementia prevalence is drawing attention to chronic pain as a potential risk factor often managed by gabapentin. Taiwanese health insurance database spanning assessed dementia risk in gabapentin-using chronic pain. The study showed that gabapentin use not linked to higher dementia risk.
by SE Tsai 2024The study showed that gabapentin use not linked to higher dementia risk. No elevated dementia risk was found across varying dosage levels or
The adjusted odds ratio for dementia risk associated with gabapentin use was 0.91 (95 % C.I. 0.83-1.01), indicating no substantial increase in risk. Conclusion: Long-term Gabapentin therapy for chronic pain is not associated with a differential risk of dementia across dosage levels, irrespective of age or gender. Further study into its
Comments